[Bio-software] CHI's 10th Anniversary Event - SBDD

JPrudhomme via bio-soft%40net.bio.net (by jprudhomme from healthtech.com)
Fri Feb 19 11:38:29 EST 2010

Dear all,

Now in its tenth year, Cambridge Healthtech Institute is accepting
registrations for its upcoming SBDD meeting:

Structure-Based Drug Design:
Multidisciplinary Innovations and Structural Insights to Enhance Drug

June 23-25, 2010
Royal Sonesta Hotel - Cambridge, Mass.


Hear from thought-leaders including:

Structure-Based Design of AP24534, a pan-BCR-ABL Inhibitor Overriding
the T315I Gatekeeper Mutation
David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD
Pharmaceuticals, Inc.

Implementation of Protein Flexibility and Water Molecules in Docking
and Scoring Methods
Nicolas Moitessier, Ph.D., Professor, Chemistry, McGill University

The Impact of Recent X-Ray Structure Determinations on Structure-Based
Drug Design for GPCRs and other CNS Targets

Sid Topiol, Ph.D., Head of US Computational Chemistry and Structural
Investigations, Chemistry, Lundbeck Research, USA

Co-Presentation: Achieving Remarkable Potency and Selectivity Against
HCV Protease by Irreversible Covalent Inhibition Using Structure-Based
Drug Design

Deqiang Niu, Ph.D., Principal Scientist/Project Leader, Medicinal
Chemistry, Avila Therapeutics
Juswinder Singh, Ph.D., Co-Founder/Chief Scientific Officer, Avila

Coupling the GPCR Structural Determination Process with Discovery and
Optimization of Small Molecule Ligands
Michael Hanson, Ph.D., Associate Director, Structural Biology,
Receptos, Inc.

Using Semi-Rational Design and Protein Folding to Engineer Highly
Specific Protein-Protein Interactions for Therapeutic Intervention
Jody Mason, Ph.D., Lecturer, Biological Sciences, University of Essex

Register by March 26th and Save up to $350

For questions or to register by phone, call 781-972-5400 or email
jprudhomme from healthtech.com

More information about the Bio-soft mailing list

Send comments to us at biosci-help [At] net.bio.net